View:
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No: )
TransMedics Group Inc
--------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------
(Title of Class of Securities)
89377M109
--------------------------------------------------------
(CUSIP Number)
December 31, 2022
--------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out
for a reporting person's initial filing on this form with
respect to the subject class of securities, and for any
subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover
page shall not be deemed to be "filed" for the purpose
of Section 18 of the Securities Exchange Act of 1934
("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
CUSIP No. 89377M109
(1)Names of reporting persons.
Sandhill Capital Partners LLC d/b/a Sandhill Investment Management
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
22-0444918
(2) Check the appropriate box if a member of a group
(a) [ ]
(b) [ ]
(3) SEC use only
(4) Citizenship or place of organization
New York
Number of shares beneficially owned by each reporting person with:
(5) Sole voting power
181412
(6) Shared voting power
0
(7) Sole dispositive power
1203750
(8) Shared dispositive power
0
(9) Aggregate amount beneficially owned by each reporting person
1203750
(10) Check if the aggregate amount in Row (9) excludes certain shares
(11) Percent of class represented by amount in Row 9
3.8%
(12) Type of reporting person
IA
Item 1.
Item 1(a) Name of issuer:
-----------------------------------------------------------------------
TransMedics Group Inc
Item 1(b) Address of issuer's principal executive offices:
-----------------------------------------------------------------------
200 MINUTEMAN ROAD
ANDOVER MA 01810
Item 2.
2(a) Name of person filing:
----------------------------------------------------------------------
Sandhill Capital Partners LLC d/b/a Sandhill Investment Management
2(b) Address or principal business office or, if none, residence:
-----------------------------------------------------------------------
40 Fountain Plaza, Suite 1300, Buffalo, NY 14202
2(c) Citizenship:
--------------------------------------------------------------------
New York, USA
2(d) Title of class of securities:
-------------------------------------------------------------------
Common Stock
2(e) CUSIP No.: 89377M109
Item 3.
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c),
check whether the person filing is a:
[ ] Broker or dealer registered under Section 15 of the Act;
[ ] Bank as defined in Section 3(a)(6) of the Act;
[ ] Insurance company as defined in Section 3(a)(19) of the Act;
[ ] Investment company registered under Section 8 of the
Investment Company Act of 1940;
[X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
[ ] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
[ ] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
[ ] A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
[ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company
Act of 1940;
[ ] A non-U.S. institution in accordance with
Rule 240.13d-1(b)(1)(ii)(J);
[ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing
as a non-U.S. institution in accordance with
Rule 240.13d-1(b)(1)(ii)(J), please specify the type of
institution:
Item 4. Ownership
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified in Item 1.
Amount beneficially owned:
1203750
Percent of class
3.8%
Number of shares as to which such person has:
Sole power to vote or to direct the vote
181412
Shared power to vote or to direct the vote
0
Sole power to dispose or to direct the disposition of
1203750
Shared power to dispose or to direct the disposition of
0
Item 5.
Ownership of 5 Percent or Less of a Class. If this statement is being
filed to report the fact that as of the date hereof the reporting person
has ceased to be the beneficial owner of more than 5 percent of the
class of securities, check the following [X].
Item 6. Ownership of More than 5 Percent on Behalf of Another Person
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company or Control Person.
Item 8. Identification and Classification of Members of the Group
Item 9. Notice of Dissolution of Group
Item 10. Certifications
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired
and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect.
Signature.
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.
Dated: February 10, 2023
Signature: Ryan Andrew Myers
-------------------------------------------
Name/Title Chief Compliance Officer